Dr. Jonathan McConathy, MD, PhD
Claim this profileUniversity of Alabama at Birmingham Medical Center
Studies Healthy Subjects
Studies Parkinson's Disease
18 reported clinical trials
17 drugs studied
Area of expertise
1Healthy Subjects
2Parkinson's Disease
rs6971 positive
TSPO rs6971 positive
Affiliated Hospitals
Clinical Trials Jonathan McConathy, MD, PhD is currently running
Advanced PET/MRI Imaging
for Breast Cancer
The purpose of the study is to see if using an investigational drug called \[18F\]FMISO with PET/MRI imaging can help monitor and predict the effect of trastuzumab (Herceptin) on chemotherapy in patients diagnosed with advanced HER2 positive breast cancer. This study is for imaging purposes only and is not a treatment study. The results of this study will not change a patient's clinical treatment plan but it may help physicians and researchers better understand how best to treat patients with breast cancer in the future.
Recruiting1 award Phase 15 criteria
PET Scan with DPA-714
for Parkinson's Disease
The primary objective of this substudy is to measure the concentration and the regional brain distribution of activated brain microglia/macrophages using the PET ligand \[18F\]DPA-714 in participants enrolled in the UAB Innate and Adaptive Immunity in Parkinson's Disease (Clinical Research Core) and Longitudinal \[18F\]DPA-714 Imaging in a Parkinson Disease Cohort studies. The PET tracer \[18F\]DPA-714 binds to the 18 kDa translocator protein (TSPO, also known as the peripheral benzodiazepine receptor) in the mitochondria of activated microglia/macrophages and provides a non-invasive measure of neuroinflammation. The amount and distribution of \[18F\]DPA-714 in the brain will be correlated to clinical data acquired through the separate ongoing UAB Innate and Adaptive Immunity in Parkinson Disease (Clinical Research Core) and Longitudinal \[18F\]DPA-714 Imaging in a Parkinson Disease Cohort studies. The primary objective of this study is to determine if patients with PD have higher levels of neuroinflammation than healthy controls as measured with \[18F\]DPA-714-PET/MRI.
Recruiting1 award Phase 1 & 2
More about Jonathan McConathy, MD, PhD
Clinical Trial Related1 year of experience running clinical trials · Led 18 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Jonathan McConathy, MD, PhD has experience with
- [18F]DPA-714
- [11C]PiB
- 18F-labeled DPA-714
- DPA-714-PET/MRI
- [Zr-89]Oxine-labeled Leukocytes PET/MRI
- [18F]FMISO
Breakdown of trials Jonathan McConathy, MD, PhD has run
Healthy Subjects
Chronic Fatigue Syndrome
Multiple Sclerosis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jonathan McConathy, MD, PhD specialize in?
Jonathan McConathy, MD, PhD focuses on Healthy Subjects and Parkinson's Disease. In particular, much of their work with Healthy Subjects has involved treating patients, or patients who are undergoing treatment.
Is Jonathan McConathy, MD, PhD currently recruiting for clinical trials?
Yes, Jonathan McConathy, MD, PhD is currently recruiting for 9 clinical trials in Birmingham Alabama. If you're interested in participating, you should apply.
Are there any treatments that Jonathan McConathy, MD, PhD has studied deeply?
Yes, Jonathan McConathy, MD, PhD has studied treatments such as [18F]DPA-714, [11C]PiB, 18F-labeled DPA-714.
What is the best way to schedule an appointment with Jonathan McConathy, MD, PhD?
Apply for one of the trials that Jonathan McConathy, MD, PhD is conducting.
What is the office address of Jonathan McConathy, MD, PhD?
The office of Jonathan McConathy, MD, PhD is located at: University of Alabama at Birmingham Medical Center, Birmingham, Alabama 35249 United States. This is the address for their practice at the University of Alabama at Birmingham Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.